RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, is pleased to announce the launch of its Fortiva™ porcine dermis implant at the Abdominal Wall Reconstruction (AWR) Conference in Washington, D.C., June 6-8. This implant positions RTI as the only provider with a comprehensive biologic solutions portfolio for use in hernia repair procedures. Tutopatch™ bovine pericardium, Tutomesh™ fenestrated bovine pericardium and Cortiva™ allograft dermis launched in March. The company’s full line of implants is distributed directly by RTI’s Surgical Specialties business unit. RTI celebrated a milestone for...
↧